INTRODUCTION
Hematopoiesis is a complex biological process in which blood cells are continuously generated from hematopoietic stem cells (HSCs) (Godin and Cumano, 2002) . In general, mammalian embryonic hematopoiesis occurs in two major waves. For example, in mice, primitive blood cells emerge in yolk sac around day 7.5 before birth, whereas definitive HSCs appear in the region of aorta-gonad-mesonephros 1-2 days later (Bertrand et al., 2005; Cumano et al., 2000; Dzierzak, 1999; Lensch and Daley, 2004; Long and Huang, 2015; Medvinsky and Dzierzak, 1996; Palis et al., 1999; Zhao and Li, 2015) . This dynamic developmental program †Contributed equally to this work *Corresponding author (email: ywang@bio.ecnu.edu.cn) requires exact orchestration of intrinsic and extrinsic signals to control HSC proliferation, differentiation, and survival (Godin and Cumano, 2002) . Multiple master transcription factors are vital determinants in this regulatory machinery and tight coordination is needed (Elefanty et al., 1997; Mankertz et al., 2004; Morrison et al., 1995; Schmitt et al., 1991) . Although genome-wide ChIP-Seq analyses implicated a combinational interaction between a heptad of transcription factors including SCL, LYL1, LMO2, GATA2, RUNX1, ERG, and FLI1 in adult HSCs (Wilson et al., 2010) , their interplay to regulate embryonic hematopoiesis is awaiting for further discovery.
The fine balance between HSC self-renewal and lineage specification is also stringently regulated by interplays between genetic and epigenetic modifiers. Among the epigenetic regulators, microRNAs (miRNAs) are a class of small 22 nt non-coding RNAs that mainly mediate post-transcriptional control of gene expression via transcript degradation or by inhibiting protein translation (Bartel, 2004; Gangaraju and Lin, 2009 ). Although there is clear evidence supporting miRNAs as important players for hematopoietic development and leukemic formation (Garzon and Croce, 2008; Vasilatou et al., 2010) , potential interactions between key transcription factors and miRNAs in embryonic hematopoiesis are yet to be understood.
The number of HSCs is very limited in both embryo and in adult bone marrow (BM) (Morrison et al., 1995) . As such, in vitro differentiation of embryonic stem cells (ESCs) provides an alternative resource for the study of regulatory events in hematopoiesis (Keller et al., 1993; Kyba and Daley, 2003; Xie and Zhang, 2015; Xie et al., 2014) . During ESC differentiation, multi-potential FLK1 + hemangioblasts developed from Brachyury + mesodermal population (Kennedy et al., 1997; Kennedy et al., 2007) , followed by the formation of CD41 + primitive HSCs (McKinney-Freeman et al., 2008; Mikkola et al., 2002) and CD45 + mono-nucleated blood cells (Hermiston et al., 2003) . In this study, we analyzed the expression of miRNAs during mouse ESC differentiation through expression arrays, and identified multiple novel miRNAs highly enriched in CD41 + and CD45 + cells. Further analyses demonstrated that these hematopoiesis-related miRNAs were regulated by a combinational interaction of key transcriptional factors in blood cells.
RESULTS

The expression of miRNAs during embryonic hematopoiesis
Previous studies demonstrated that ESCs could differentiate into three-dimensional structures called embryoid bodies (EBs) and mimic primitive hematopoietic development in vitro (Keller et al., 1993; Kyba and Daley, 2003; Wang et al., 2005) . To understand the role of miRNAs in this process, we utilized the in vitro differentiation system of mouse ESCs with a GFP transgene driven by the Brachyury (T) promoter. T-GFP + (mesodermal population), FLK + (multi-potential hemangioblasts), CD41 + (hematopoietic precursors), and CD45 + cells (mononuclear blood cells) were isolated at various time points along EB differentiation ( Figure 1A) , and microarray analyses were performed. More than 200 miRNAs demonstrated differential expression levels in these sorted populations. Among them, several hematopoiesis-related miRNAs (including miR-451, miR-142, and miR-146a/b, etc. (Chen et al., 2004; Fatica et al., 2006; Garzon and Croce, 2008; Vasilatou et al., 2010) ) were highly enriched in CD41 + and/or CD45 + cells ( Figure 1B ). By contrast, miRNAs implicated in maintaining pluripotency, such as miR-302, miR-293/295, and miR-363, etc. (Gruber et al., 2014; Houbaviy et al., 2003; Judson et al., 2009; Wang et al., 2008) , were significantly down regulated in those isolated blood cells from ESCs ( Figure 1B) . Importantly, we found increased levels of several miRNAs such as miR-10b and miR-15a in CD41 + or CD45 + cells ( Figure 1B) . Roles of these miRNAs in hematopoiesis are unknown but our data suggest their potential functions in blood formation.
To confirm these results, we further utilized another ESC line, Ainv15, and compared the expression of these miRNAs from sorted CD41 + or CD45 + cells with CD41 -or CD45 -populations by real-time RT-PCR analyses. Indeed, the miRNAs that demonstrated an increased expression in blood cells compared to T-GFP + mesodermal precursors were enriched in the CD41 + or/and CD45 + populations ( Figure 1C and D), whereas miRNAs that were highly expressed in ESCs showed decreased levels in CD41 + and/or CD45 + cells compared to their negative controls ( Figure 1C and D) , demonstrating a high quality of the microarray data.
Promoters of miRNAs are bound by multiple key transcription factors in hematopoiesis
We next explored the upstream regulators of these miRNAs enriched in blood cells with promoter analyses ( Figure  2A ). Among the transcription factors we examined, GATA3 and SCL were master regulators involved in both primitive and definitive hematopoiesis (Chen and Zhang, 2001; Gao et al., 2016; Porcher et al., 1996) , whereas EKLF (or KLF1) and PU.1 participated in erythropoiesis and lymphogenesis respectively (Lohmann and Bieker, 2008; Nerlov and Graf, 1998) . Interestingly, binding motifs of multiple transcription factors including EKLF and PU.1 that participated in those different processes of hematopoiesis were identified at adjacent motifs within the same promoter regions of miR-144/451, miR-223, and miR-142 ( Figure  2A ). To confirm these results, Chromatin Immuno Precipitation (ChIP)-PCR assays were performed in MEL (a mouse erythroleukemia line) with enforced expression of FLAG-tagged GATA3, EKLF, and PU.1. Indeed, all three transcription factors were bound at the predicated regions in promoters of target miRNAs ( Figure 2B ). For example, although miRNA-144 was believed to play a role in erythrocyte formation, several binding motifs for GATA3, EKLF, and PU.1 were found to be co-localized at 400-500 bp upstream of transcription start site (TSS) for miRNA-144 ( Figure 2A and B). These results thus suggest that EKLF and PU.1 may cooperate to fine-tune the transcript level of miRNA-144 in erythrocytes and myeloid/lymphoid lineages. Taken together, our data demonstrate a combinational cooperation of transcription factors for regulating the expression of miRNAs involved in hematopoiesis.
Expression of multiple miRNAs is regulated by key transcription factors in hematopoiesis
We next examined whether these key transcription factors Gong, X., et al. Sci China Life Sci February (2017) indeed regulated the expression of their target miRNAs by a firefly and renilla dual luciferase reporter assay. In this assay, firefly luciferase driven by promoters of miRNAs was co-transfected with expressing plasmids encoding renilla luciferase and FLAG-tagged transcription factors into 293T cells, and relative firefly (to renilla) luciferase activity was measured at 24-48 h post transfection. Consistent with the prediction and ChIP-PCR data above, the master regulator, GATA3, demonstrated the strongest upregulation of all miRNAs we tested, whereas EKLF and PU.1 exhibited a differential modulation of miRNA expression in this assay ( Figure 3A ). In addition, GFI1b mainly upregulated the expression of miR-142 ( Figure 3A) . By contrast, overexpression of AML1, a protein involved in both self-renewal of hematopoietic stem cells and myeloid-lymphoid formation, decreased the transcript levels of all four miRNAs ( Figure  3A ), suggesting that a general inhibitory co-factor for AML1 may exist in 293T cells.
We further examined the transcript levels of the miRNA precursors (pri-miRNAs) by real-time RT-PCRs in MEL cells upon enforced expression of these transcription factors. Indeed, GATA3 showed a dramatic upregulation of miR-144 and miR-223, while EKLF mainly increased the expression of both miR-144/451 and miR-142 ( Figure 3B ). In addition, ETS family members including FLI1 and ERG upregulated miR-142 and miR-223, but decreased the level of miR-144/451 pri-miRNAs ( Figure 3B) . Notably, the regulatory roles of these factors were not exactly the same as those observed in 293T cells. For example, ectopic AML1 expression displayed an inhibition of all four miRNAs that we examined in 293T cells, but this suppression was not observed in MEL ( Figure 3B ). By contrast, AML upregulated the transcript level of miRNA-223 ( Figure 3B ). These result support the importance of setting and specificity of blood cells (eg. MEL) in which transcriptional regulators are needed to perform their biological functions.
To further understand the upstream regulators of miRNAs during hematopoiesis in vivo, we established multiple conditional ESC lines in which the expression of key transcriptional factors was induced upon treatment of doxycycline ( Figure 4A-D) . In this assay, we found that SCL and EKLF, the genes that were reported to be involved in eryth- Gong, X., et al. Sci China Life Sci February (2017) 
Figure 3
The expression of miRNAs were regulated by combinational control of multiple transcription factors. A, Luciferase activities driven by upstream promoter regions of miRNAs were examined upon co-transfection of luciferase reporter plasmids and transgenes to express transcription factors or an empty vector control. Relative firefly luciferase activity to the Renilla transfection control is represented as mean±SE of replicates from at least three independent experiments. B, Relative pri-miRNA levels upon enforced expression of various transcription factors in MEL cells were examined by real-time RT-PCR assays. Data were represented as mean±SE of replicates from at least three independent experiments. *, P<0.05; **, P<0.01; ***, P<0.001. ropoiesis mainly upregulated miR-144/451 and miR-142, whereas FLI1 and ERG, the key factors in megakaryocyte formation (Kruse et al., 2009) , significantly increased the expression of miR-142 and miR-146b ( Figure 4A-D) , implicating distinct roles of their target miRNAs during primitive hematopoiesis.
Differential effects of microRNAs on hematopoiesis during ESC differentiation
To explore the functions of miRNAs during embryonic hematopoiesis, we established conditional miRNA ESC lines, in which the expression of miRNAs was enforced by doxycycline treatment ( Figure 5A ). We previously reported that CD71 high population derived from ESCs represents primitive erythroid precursors (Chao et al., 2014) , whereas CD45 marked differentiated mononuclear blood cells (Hermiston et al., 2003) , with CD41 as a marker for primitive HSCs (McKinney-Freeman et al., 2008; Mikkola et al., 2002) . During ESC in vitro differentiation, we found that both miR-142 and miR-146b transiently increased the formation of CD71 high population ( Figure 5B ), indicating previously unknown functions of these miRNAs in primitive erythro- poiesis. In addition, the percentage of CD41 + cells was upregulated upon induction of miR-146b ( Figure 5B ), suggesting a role of this miRNA in primitive hematopoiesis. Surprisingly, there was no obvious alteration in formation of CD71 high population upon enforced expression of miR-144/451, a previously reported miRNA in the erythroid formation (Patrick et al., 2010) . It is possible that sole overexpression of miR-144/451 was not sufficient to induce primitive erythroid fate specification during ESC differentiation.
Interestingly, although these miRNAs participate in hematopoiesis, many of their potential target genes are the same key transcription factors that regulate miRNA expression in blood development ( Figure 6A ). For example, bioinformatics prediction indicated that miR-144/451 targeted 3′-UTR of FLI1 and ERG, which in turn appeared to inhibit the expression of miR-144/451, and thus formed a negative interactive feedback loop (Figure 6 ). In addition, our data suggested GATA3 and SCL activated the expression of miR-144/451 in HSCs, in turn miR144 might target GATA3 and SCL (via bioinformatics prediction) to facilitate erythrocyte fate specification at later stages of hematopoiesis. Similarly, whereas EKLF upregulated miR-223 level, miR-223 likely targeted EKLF to negatively regulate erythrocyte formation in myeloid lineages ( Figure  6 ). Taken together, these data demonstrated that key transcription factors and miRNAs interact with each other to fine-tune their expression and function during hematopoietic development. Gong, X., et al. Sci China Life Sci February (2017) 
DISCUSSION
Although many miRNAs have been demonstrated to be important during definitive hematopoiesis and leukemic formation in adulthood, roles of these miRNAs in embryonic primitive blood development are yet to be understood. In this study, we identified more than 20 miRNAs that were highly enriched in primitive hematopoiesis from mouse ESCs, including the ones that had not been previously reported (e.g. miR-10b). These data thus support the notion that ESC in vitro differentiation system is a powerful platform to identify novel regulators during embryonic development.
To gain knowledge in transcriptional regulation is key to understand the mechanism that governs complex biological processes such as hematopoiesis. Previous studies demonstrated that transcriptional factors at the same stage of adult hematopoiesis cooperated to regulate their downstream targets (Wilson et al., 2010) . Our bioinformatics prediction and ChIP-PCR analyses suggest that multiple key transcription factors from distinct steps of hematopoiesis are also co-localized at adjacent positions at promoters of their targeted miRNAs. This observation reveals a combinational coordination and functional relevance among these transcriptional regulators. Alternatively, these miRNAs may play multiple roles at distinct stages of hematopoietic development. In addition, although reporter assays in 293T cells indicated an upregulation of luciferase activity driven by the promoter of miR-142 upon GATA3 overexpression, the level of miR-142 was not changed by increased level of GATA3 in MEL, an erythroleukemic line (Figure 3) . Similarly, SCL enhanced the expression of miR-223 only in hematopoietic population (Figure 3) , suggesting that additional factors in blood cells may be needed in coordination with GATA3 or SCL to modulate the expression of their targeted miRNAs.
It was previously demonstrated that SCL and EKLF promoted erythropoiesis, whereas ETS family members, such as ERG and FLI1, enhanced megakaryopoietic differentiation by inhibiting erythrocyte formation (Kruse et al., 2009; Starck et al., 2010) . We found that both SCL and EKLF increased the expression of miR-144/451, whereas FLI1 downregulated miR-144/451, in turn miR-144/451 might target FLI1 to inhibit its expression in erythrocytes, thus forming a negative feedback circuitry to fine-tune the formation of red blood cells. Similarly, miR-223, a miRNA implicated in myeloid-lymphocyte formation (Fazi et al., 2005) , might target 3′-UTR of EKLF and repress it expression in myeloid cells. Interestingly, ETS family members, SCL, and EKLF all enhanced the expression of miR-142, suggesting its role in both erythropoietic and megakaryopoietic development. Indeed, we observed that enforced expression of miR-142 or miR-146b transiently increased the formation of CD71 high population from ESCs, indicating previously unknown roles of these miRNAs in primitive erythropoiesis. Taken together, our data demonstrated a combinational interplay between key transcription factors and miRNAs during embryonic hematopoiesis.
MATERIALS AND METHODS
Plasmid construction
Mouse AML1, ERG, FLI1, GATA1, GATA3, GFI1B, LYL1, MEIS1, PU.1 and SCL were amplified from a cDNA library of mouse differentiated ESCs and cloned in fusion with a 1×FLAG tag into plvx-IRES-zsgreen for luciferase reporter assay, or into pll3.7-IRES-GFP for retroviral infections of MEL cells. Similarly, ERG, EKLF and FLI1 cDNAs were cloned into plox for inducible expression of these transcription factors. For construction of inducible expression of primiRNAs, about 300 bp upstream and downstream of flanking regions of mature miRNAs were amplified from mouse genomic DNA and cloned into plox plasmid. Primers for cloning in this study are listed in Table S1 in Supporting Information.
ESC cell culture and differentiation
Mouse ESCs were cultured on irradiated mouse embryonic fibroblasts (MEFs) in high glucose Dulbecco's modified eagle medium (DMEM) supplemented with 15% fetal bovine serum (FBS), 2 mmol L -1 L-glutamine, 100 U mL -1 penicillin and streptomycin (all from Gibco-BRL, USA), 1000 U mL penicillin and streptomycin, all others from Gibco-BRL), and plated for 45 min to allow MEFs to adhere. Non-adherent ESCs were collected and plated in hanging drops at 500 cells per 15 μL drop in an inverted bacterial petri dish. Embryoid bodies (EBs) were collected at day 2 and transferred into 10 mL EB differentiation medium in slowly rotating 10 cm petri dishes. Cells were harvested at different time points by collagenase treatment. To induce gene expression, 0.5-1 μg mL -1 doxycycline was added to the culture medium from day 2. Stable ESC lines were established by selection of hygromycine resistant ESCs after electroporation. MEL cells were cultured in RPMI-1640 medium supplemented with10% FBS, 100 μg mL -1 streptomycin, and 100 U mL -1 penicillin.
Generation of the doxycycline-inducible ESC lines
The protocol to generate doxycycline inducible ESC lines was published previously (Kyba et al., 2002; Wang et al., 2005) . In brief, the parental ESC line Ainv15, was electroporated with 20 μg plox-ERG, plox-EKLF, or plox-FLI1, together with 20 μg the Cre recombinase expression plasmid, pSalk-Cre, followed by selection in ESC culture medium with 150 μg mL -1 hygromycine (GIBCO). Individual colonies were picked at day 12 post drug treatment for further expansion. The ESC line with inducible SCL expression is a kind gift from Dr. George Daley's lab at Harvard Medical School.
Flow cytometry analysis and cell sorting
Dissociated EB cells were incubated with appropriate primary antibodies for 30 min at 4°C, washed twice, and analyzed with FACSCalibur (BD Biosciences, USA) for analy-ses or sorted with FACSAria II (BD Biosciences). All monoclonal antibodies used in this study were purchased in fluorochrome-coupled forms from BD Pharmingen.
Total RNA preparation, RT-PCR, and quantitative realtime PCR
Total RNAs were extracted with Trizol (Invitrogen, USA) and cDNAs were synthesized using a PrimeScript ® RT reagent Kit (TaKaRa, Japan). Real-time PCR was performed on a Stratagene MX3000P instrument and analyzed as described previously (Wang et al., 2013) . Primers used in this study are listed in Table S1 in Supporting Information.
Chromatin immunoprecipitation
Cells were cross-linked with 1% formaldehyde and sonicated into 200 bp fragments. The cell lysate was precleared before being immunoprecipitated with a FLAG antibody (Sigma) or control IgG. Followed by a pull-down with protein A/G beads (Santa Cruz Biotechnology, USA), a subsequent series of washes, and elution, enrichment of targeted DNA fragments was finally examined by real-time RT-PCR. Primers for ChIP-PCR used in this study are listed in Supplementary  Table 1 .
Luciferase reporter assay
The upstream DNA fragments of mouse miR-144/451, miR-223, and miR142 were amplified by PCR and cloned into pGL4-basic firefly luciferase reporter vector. The reporter plasmid was then co-transfected into 293T cells with a Renilla-luciferase expressing vector, and plvx-ires-zsgreen plasmid containing transgenes of transcription factor driven by a CMV promoter. The activity of firefly relatively to renilla luciferase was measured with a luciferase assay kit (Promega, USA).
Microarray assay
The GFP + (Brachyury-GFP), Flk1 + , CD41 + , and CD45 + cells were sorted at different time points along EB differentiation by flow cytometer. Gene expression analyses were conducted with Agilent Whole Mouse Genome (014868) 4×44 multiplex format oligo arrays (Agilent technologies, USA) following the Agilent 1-color microarray-based gene expression analysis protocol. Starting with 500 ng of the total RNA, Cy3 labeled cRNAs was produced according to manufacturer's protocol. For each sample, 1.65 μg of Cy3 labeled cRNAs was fragmented and hybridized for 17 h in a rotating hybridization oven. Slides were washed and scanned with an Agilent Scanner. Data were obtained using the Agilent Feature Extraction software (v9.5), using the 1-color default for all parameters. The Agilent Feature Extraction software was also used for error modeling, adjusting for additive and multiplicative noises. The final data were processed using Rosetta Resolver system (v7.2, Rosetta Biosoftware, USA).
Prediction of transcription factor binding sites and miRNA target genes
Transcription factor binding sites at the promoters of miRNAs were predicted by the R programming language (https://www.bioconductor.org/) and the binding matrix was obtained from http://www.gene-regulation.com/pub/databases.html and http://jaspar.genereg.net/. The miRNA target genes and binding motifs were predicted via http://www.targetscan.org.
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